Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors. This activity is useful for the treatment of hypertension, severe pain, and ADHD.
Clonidine was granted FDA approval on 3 September 1974.
Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications. A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient. An extended release tablet of clonidine is indicated for the treatment of ADHD either alo...
Department of Psychiatry and Psychotherapy, Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
Univerzita Karlova v Praze, Prague, Czechia
University of Erlangen-Nürnberg Medical School, Erlangen, Germany
Hospital Universitario 12 de Octubre, Madrid, Spain
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Mercy Facial Plastic Surgery Center, Springfield, Missouri, United States
Steadman Hawkins Clinic of the Carolinas - Greenville Health System, Greenville, South Carolina, United States
Steadman Hawkins Clinic of the Carolinas - Greenville Health System, Greenville, South Carolina, United States
Republic Vilnius University Hospital, Vilnius, Lithuania
Køge Sygehus, Anæstesiologisk Afdeling, Køge, Denmark
The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Zealand, Denmark
Anæstesiologisk afdeling, Vejle Sygehus, Vejle, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.